80. 甲状腺ホルモン不応症 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 1 / 薬物数 : 5 - (DrugBank : 3) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 3
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
Levothyroxine
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;
Thyrotropin Releasing Hormone (TRH)
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;
Thyrotropin Releasing Hormone (TRH)
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States;